← Back to contracts

Defining epigenetic mechanisms in NPM1c mutant leukemia

US · IL National Institutes of Health grant awarded #nih-5R01CA259273-05

Summary

This project aims to define the epigenetic mechanisms in NPM1c mutant leukemia, focusing on the roles of the histone methyltransferase MLL and its adaptor protein Menin, to advance understanding and improve future treatment strategies.

What they want

The project will develop a comprehensive understanding of the chromatin state in the presence of NPM1c mutations, specifically focusing on the roles of Menin and MLL. This includes determining changes in chromatin state upon NPM1c degradation and identifying essential protein domains of NPM1c. It will also identify transcriptional activators and chromatin modifiers that associate with the Menin-MLL complex in NPM1c mutant leukemias, leading to aberrant target gene activation. Finally, the project will investigate the chromatin binding factor LEDGF, which associates with Menin-MLL and recruits transcriptional activators, to understand its dependency in NPM1c mutant leukemia cells and its interaction with Menin-inhibition.
Deliverables
  • Determination of changes in chromatin state upon NPM1c degradation
  • Determination of essential protein domains of NPM1c
  • Identification of transcriptional activators and chromatin modifiers associated with the Menin-MLL complex in NPM1c mutant leukemias
  • Investigation of the chromatin binding factor LEDGF's role in NPM1c mutant leukemia cells and its interaction with Menin-inhibition
  • Advanced mechanistic understanding of NPM1c driven leukemia development
Defining epigenetic mechanisms in NPM1c mu…
Onboard